Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin as preoperative preparation for myasthenia gravis surgery
2012-001544-21Phase 2Active
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of immune globulin in myasthenia gravis (MG), sponsored by Vall d'Hebron Research Institute. Primary endpoint: incidence of myasthenic crises. Started Aug 2012; status: active.
02
Drugs
immune globulin
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on 2012-001544-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001544-21.